Schedule 13D ownership disclosure
EVOKE PHARMA INC
Security class unavailable · CUSIP: 30049G203
Event date: 2024-11-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-114818
- Form type
- SC 13D
- Filer
- Evoke Pharma Inc
- CIK
- CIK 1403708
- Filed
- Nov 06, 2024
- Reporting period
- Nov 06, 2024
- Description
- Schedule 13D beneficial ownership